The current pharmaceuticals, medicinal chemicals, seasonally adjusted index in Serbia is 165.6, which has increased by 0.7 (0.4%) since 2023 Q4.
Pharmaceuticals, medicinal chemicals, seasonally adjusted index in Serbia
No matching regions
Data availability:
Regions:
82
Date range: 2005 Q1 to 2024 Q1
Points:
5,455
Measure:
Index
Similar regions to Serbia
Pharmaceuticals, medicinal chemicals
Serbia Pharmaceuticals, medicinal chemicals between 2005 Q1 and 2024 Q1
| Period | Pharmaceuticals, medicinal chemicals | Change |
|---|---|---|
| 2024 Q1 | 165.6 | +0.7 |
| 2023 Q4 | 164.9 | +1.3 |
| 2023 Q3 | 163.6 | +6.5 |
| 2023 Q2 | 157.1 | +2.2 |
| 2023 Q1 | 154.9 | +7.7 |
| 2022 Q4 | 147.2 | +3.7 |
| 2022 Q3 | 143.5 | -2.1 |
| 2022 Q2 | 145.6 | +3.1 |
| 2022 Q1 | 142.5 | -3.0 |
| 2021 Q4 | 145.5 | +7.1 |
| 2021 Q3 | 138.4 | +5.6 |
| 2021 Q2 | 132.8 | +1.4 |
| 2021 Q1 | 131.4 | +6.3 |
| 2020 Q4 | 125.1 | -5.9 |
| 2020 Q3 | 131.0 | -3.3 |
| 2020 Q2 | 134.3 | +0.9 |
| 2020 Q1 | 133.4 | -0.6 |
| 2019 Q4 | 134.0 | +6.1 |
| 2019 Q3 | 127.9 | +3.0 |
| 2019 Q2 | 124.9 | +4.1 |
| 2019 Q1 | 120.8 | 0.0 |
| 2018 Q4 | 120.8 | +19.8 |
| 2018 Q3 | 101.0 | -13.9 |
| 2018 Q2 | 114.9 | -0.4 |
| 2018 Q1 | 115.3 | +1.1 |
| 2017 Q4 | 114.2 | +1.5 |
| 2017 Q3 | 112.7 | 0.0 |
| 2017 Q2 | 112.7 | +1.6 |
| 2017 Q1 | 111.1 | +4.8 |
| 2016 Q4 | 106.3 | +1.5 |
| 2016 Q3 | 104.8 | +3.3 |
| 2016 Q2 | 101.5 | +2.8 |
| 2016 Q1 | 98.7 | -1.8 |
| 2015 Q4 | 100.5 | +0.7 |
| 2015 Q3 | 99.8 | +0.6 |
| 2015 Q2 | 99.2 | -1.3 |
| 2015 Q1 | 100.5 | +4.5 |
| 2014 Q4 | 96.0 | +0.1 |
| 2014 Q3 | 95.9 | -0.7 |
| 2014 Q2 | 96.6 | +2.3 |
| 2014 Q1 | 94.3 | +1.5 |
| 2013 Q4 | 92.8 | -6.4 |
| 2013 Q3 | 99.2 | -0.7 |
| 2013 Q2 | 99.9 | -0.4 |
| 2013 Q1 | 100.3 | -1.4 |
| 2012 Q4 | 101.7 | +15.0 |
| 2012 Q3 | 86.7 | +5.4 |
| 2012 Q2 | 81.3 | +3.4 |
| 2012 Q1 | 77.9 | +1.0 |
| 2011 Q4 | 76.9 | -3.3 |
| 2011 Q3 | 80.2 | +1.7 |
| 2011 Q2 | 78.5 | +2.4 |
| 2011 Q1 | 76.1 | +2.3 |
| 2010 Q4 | 73.8 | +1.5 |
| 2010 Q3 | 72.3 | -2.0 |
| 2010 Q2 | 74.3 | -0.1 |
| 2010 Q1 | 74.4 | +0.5 |
| 2009 Q4 | 73.9 | -1.1 |
| 2009 Q3 | 75.0 | -0.7 |
| 2009 Q2 | 75.7 | -6.8 |
| 2009 Q1 | 82.5 | -4.0 |
| 2008 Q4 | 86.5 | -4.7 |
| 2008 Q3 | 91.2 | -0.5 |
| 2008 Q2 | 91.7 | +3.7 |
| 2008 Q1 | 88.0 | +3.2 |
| 2007 Q4 | 84.8 | +7.1 |
| 2007 Q3 | 77.7 | +2.8 |
| 2007 Q2 | 74.9 | -1.6 |
| 2007 Q1 | 76.5 | -2.2 |
| 2006 Q4 | 78.7 | -5.1 |
| 2006 Q3 | 83.8 | +1.1 |
| 2006 Q2 | 82.7 | +4.2 |
| 2006 Q1 | 78.5 | +4.7 |
| 2005 Q4 | 73.8 | +3.1 |
| 2005 Q3 | 70.7 | +1.8 |
| 2005 Q2 | 68.9 | +2.1 |
| 2005 Q1 | 66.8 |